Ten Years of Denosumab Treatment in Postmenopausal Women With Osteoporosis: Results from the FREEDOM Extension Trial

被引：0

作者：

Bone, Henry ^{[1
]}

Brandi, Maria-Luisa ^{[2
]}

Brown, Jacques ^{[3
]}

Chapurlat, Roland ^{[4
]}

Cummings, Stephen ^{[5
]}

Czerwinski, Edward ^{[6
]}

Fahrleitner-Pamer, Astrid ^{[7
]}

Kendler, David ^{[8
]}

Lippinur, Kurt ^{[9
]}

Reginster, Jean-Yves ^{[10
]}

Vittinghoff, Eric ^{[11
]}

Daizadeh, Nadia ^{[12
]}

Wang, Andrea ^{[12
]}

Dakin, Paula ^{[12
]}

Wagman, Rachel ^{[12
]}

Papapoulos, Socrates ^{[13
]}

机构：

[1] Michigan Bone & Mineral Clin, Detroit, MI USA

[2] Univ Florence, Azienda Osped Careggi, I-50121 Florence, Italy

[3] CHU Quebec, Quebec City, PQ, Canada

[4] Hop Edouard Herriot, Lyon, France

[5] San Francisco Coordinating Ctr, CPMC Res Inst, San Francisco, CA USA

[6] Krakow Med Ctr, Krakow, Poland

[7] Med Univ Graz, Graz, Austria

[8] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada

[9] Univ Hosp Bern, Bern, Switzerland

[10] Univ Liege, Liege, Belgium

[11] UCSF, San Francisco, CA USA

[12] Amgen Inc, Thousand Oaks, CA 91320 USA

[13] Leiden Univ, Med Ctr, Leiden, Netherlands

来源：

JOURNAL OF RHEUMATOLOGY | 2016年 / 43卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

151

引用

页码：1209 / 1209

页数：1

共 50 条

[31] DENOSUMAB REDUCED OSTEOPOROTIC FRACTURES IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS WITH PRIOR FRACTURE: RESULTS FROM FREEDOM
Palacios, Santiago
Rizzoli, R.
Zapalowski, C.
Resch, H.
Adami, S.
Adachi, J. D.
Gallagher, J. C.
Feldman, R. G.
Kendler, D. L.
El-Haschimi, K.
Wang, A.
Wagman, R. B.
Boonen, S.
OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S299 - S300
[32] The DATA Extension Study: 2 Years of Combined Denosumab and Teriparatide in Postmenopausal Women with Osteoporosis: A Randomized Controlled Trial
Leder, Benjamin
Uihlein, Alexander
Tsai, Joy
Neer, Robert
Siwila-Sackman, Erica
Zhu, Yuli
Foley, Katelyn
Lee, Hang
Burnett-Bowie, Sherri-Ann
JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
[33] Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial
Leder, Benjamin Z.
Tsai, Joy N.
Uihlein, Alexander V.
Burnett-Bowie, Sherri-Ann M.
Zhu, Yuli
Foley, Katelyn
Lee, Hang
Neer, Robert M.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (05): : 1694 - 1700
[34] Update on Denosumab Treatment in Postmenopausal Women with Osteoporosis
Min, Yong-Ki
ENDOCRINOLOGY AND METABOLISM, 2015, 30 (01) : 19 - 26
[35] Denosumab treatment in postmenopausal women with osteoporosis reply
Bone, Henry G.
Wagman, Rachel B.
Pannacciulli, Nicola
Papapoulos, Socrates
LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (10): : 768 - 769
[36] Extended Safety Observations From Denosumab Administration in Postmenopausal Women From the FREEDOM and FREEDOM Extension Trials
Brown, J. P.
Bone, H. G.
Chapurlat, R.
Libanati, C.
Brandi, M. L.
Czerwinski, E.
Krieg, M. -A.
Man, Z.
Mellstrom, D.
Radominski, S. C.
Reginster, J. -Y.
Resch, H.
Roman Ivorra, J. A.
Roux, Christian
Daizadeh, N. S.
Grauer, A.
Cummings, S. R.
Papapoulos, S.
ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S431 - S432
[37] Evaluation of Invasive Oral Procedures and Events in Women With Postmenopausal Osteoporosis Treated for up to 10 Years With Denosumab: Results From the Phase 3 FREEDOM Open-label Extension.
Watts, Nelson B.
Butler, Peter W.
Binkley, Neil
Grbic, John T.
McClung, Michael
Tierney, Antoniette
Wagman, Rachel B.
Yin, Xiang
JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S5 - S5
[38] Ten years' experience with alendronate for osteoporosis in postmenopausal women
Bone, HG
Hosking, D
Devogelaer, J
Tucci, JR
Emkey, RD
Tonino, RP
Rodriguez-Portales, JA
Downs, RW
Gupta, J
Santora, AC
Liberman, UA
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (12): : 1189 - 1199
[39] Denosumab for the treatment of postmenopausal osteoporosis
Lewiecki, E. Michael
WOMENS HEALTH, 2009, 5 (01) : 15 - 22
[40] Denosumab for treatment of postmenopausal osteoporosis
Chitre, Mona
Shechter, David
Grauer, Andreas
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (15) : 1409 - 1418

← 1 2 3 4 5 →